INC Research Reaches Major Trusted Process® Milestone with 500th QuickStart® Camp
Raleigh, N.C., Dec. 13, 2012 - INC Research, LLC, a therapeutically focused clinical research organization (CRO), today announced it has reached a major milestone with its metrics-driven clinical...
Patheon Completes Acquisition of Banner Pharmacaps
TORONTO, Dec. 14, 2012 /CNW/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, today announced that it has...
Warnex to Sell its Bioanalytical Services Division
Laval, Quebec, October 25, 2012 - Warnex Inc. (TSXV: WNX) ("Warnex" or the "Corporation") is pleased to announce that it has entered into a binding agreement (the...
Warnex Completes the Sale of its Bioanalytical Services Division and Implements the Consolidation of its Common Shares
LAVAL, QUEBEC–(Marketwire – Dec. 11, 2012) – Warnex Inc. (TSX VENTURE:WNX) ("Warnex" or the "Corporation") is pleased to report that it has successfully completed the previously...
Charles River Laboratories Provides 2013 Financial Guidance
WILMINGTON, Mass.--Charles River Laboratories International, Inc. (NYSE: CRL) today provided guidance for 2013 and reaffirmed guidance for 2012. James C. Foster, Chairman, President and Chief...
Catalent and UMN Pharma announce collaboration for Biosimilar Development and Production in Japan
Somerset, NJ & Akita, Japan – December 13, 2012 — Catalent Pharma Solutions and UMN Pharma Inc. today announced the signing of an agreement to provide UMN Pharma a broad range of...
Experimental Agent Briefly Eases Depression Rapidly in Test
Works in Brain like Ketamine, with Fewer Side Effects – NIH Trial A drug that works through the same brain mechanism as the fast-acting antidepressant ketamine briefly improved...
Novella Clinical Bolsters Business Development with Three New Hires
Novella Clinical Bolsters Business Development with Three New Hires RESEARCH TRIANGLE PARK, N.C., December 11, 2012 - Novella Clinical, a full service contract research organization (CRO), today...
Clinipace Worldwide's Ran Frenkel Promoted to Managing Director, EMEA
Clinipace Worldwide's Ran Frenkel Promoted to Managing Director, EMEA MORRISVILLE, N.C. December 13, 2012 – Clinipace Worldwide, a global digital contract research organization (dCRO), today...
INC Research Appoints New Chief Information Officer to Lead Data Intelligence Initiatives
INC Research Appoints New Chief Information Officer to Lead Data Intelligence Initiatives Seasoned IT Leader to Drive Global Efficiency Using Advanced IT Strategies Raleigh, N.C., Dec. 10, 2012...
INC Research Strengthens Leadership for Strategic Advisory Services Unit
INC Research Strengthens Leadership for Strategic Advisory Services Unit Robert Ryan, PhD, appointed Vice President, Regulatory Strategy, Consulting and Submissions Raleigh, N.C., Dec. 6, 2012...
Perceptive Informatics Opens First Customer Care Office in China
BOSTON, Dec. 10, 2012 -- Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that it has opened a...
TFS International acquires all shares of DIMENSIONE RICERCA
On November 30th, 2012 TFS International (TFS) has signed an agreement to acquire DIMENSIONE RICERCA (DR), an independent clinical contract research organization (CRO), based in Rome and Milan,...
Recipharm invests in Analytical Development Services
Recipharm has today announced a significant strategic investment to expand capacity in analytical services and stability studies at its facility in Solna, Sweden. The facility is equipped with...
Covance Receives SFDA GLP Certification for Its Early Development Facility in Shanghai, China
PRINCETON, N.J. -- Covance Inc. (NYSE: CVD) today announced that its early development facility located in Shanghai, China, has received a Good Laboratory Practice (GLP) Certificate from the State...
Alimera Sciences Signs Agreement With Quintiles for European Commercial Launch of ILUVIEN®
ATLANTA, Dec. 4, 2012 -- Alimera Sciences, Inc., (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic...
AMRI Extends Long Term Supply Relationship with GE Healthcare
Albany, NY (December 6, 2012) – AMRI (Nasdaq: AMRI) today announced the extension of a commercial supply relationship with GE Healthcare (NYSE: GE) for Aminobisamide Hydrochloride (ABA). Under...
Dennis Gillings Receives SCRIP Lifetime Achievement Award, Quintiles Named CRO of the Year
RESEARCH TRIANGLE PARK, N.C.--Quintiles Founder Dennis Gillings, CBE, has received the SCRIP Lifetime Achievement Award and the company he started has been named "CRO of the Year" at the 2012 SCRIP...
NextPharma completes sale of US affiliate
London, UK, 29th November 2012 – NextPharma Technologies Holding Limited, one of the leading contract manufacturers in Europe for the pharmaceutical, biotechnology and healthcare industries, is...
Selecta Biosciences and Sanofi Sign Global Collaboration to Develop Antigen-Specific Immunotherapies for up to Three Allergy Indications Based on Selecta's Synthetic Vaccine Particle Technology
Collaboration starts with immunotherapy for life-threatening food allergies Novel therapies engineered to produce immune tolerance for two additional antigens to abate allergic immune response in...
